You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 31, 2025

Drug Price Trends for AMOXICILLIN


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for AMOXICILLIN

Average Pharmacy Cost for AMOXICILLIN

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug NameNDCPrice/Unit ($)UnitDate
AMOXICILLIN 250 MG CAPSULE 60687-0776-01 0.07872 EACH 2025-03-26
AMOXICILLIN 500 MG CAPSULE 60687-0787-01 0.09188 EACH 2025-03-26
AMOXICILLIN 500 MG CAPSULE 60687-0787-11 0.09188 EACH 2025-03-26
AMOXICILLIN 250 MG CAPSULE 60687-0776-11 0.07872 EACH 2025-03-26
>Drug Name>NDC>Price/Unit ($)>Unit>Date
Showing 1 to 4 of 4 entries

Best Wholesale Price for AMOXICILLIN

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)UnitDatesPrice Type
AMOXICILLIN-POT CLAVULANATE 1000MG/62.5MG Sandoz, Inc. 00781-1943-39 40 241.02 6.02550 EACH 2023-08-15 - 2028-08-14 FSS
AMOXICILLIN 500MG CAP Sandoz, Inc. 00781-2613-05 500 46.91 0.09382 EACH 2023-08-15 - 2028-08-14 FSS
AMOXICILLIN 250MG CAP Sandoz, Inc. 00781-2020-05 500 30.33 0.06066 EACH 2023-08-15 - 2028-08-14 FSS
AMOXICILLIN 500MG CAP Sandoz, Inc. 00781-2613-01 100 10.45 0.10450 EACH 2023-08-15 - 2028-08-14 FSS
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Unit>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 1 to 4 of 4 entries

Market Analysis and Price Projections for Amoxicillin

Global Amoxicillin Market Overview

The global amoxicillin market is poised for significant growth driven by several key factors. As of 2024, the market was valued at approximately $4.9 billion and is expected to reach $6.1 billion by 2033, growing at a Compound Annual Growth Rate (CAGR) of 2.5%[1][3][4].

Market Drivers

  • Increasing Prevalence of Bacterial Infections: The rising incidence of bacterial infections such as respiratory tract infections, urinary tract infections, and skin infections is a major driver of the market. This increasing demand for effective antibiotic therapy fuels the growth of the amoxicillin market[1][3][4].
  • Antibiotic Resistance and Need for Effective Therapy: The emergence of antibiotic-resistant bacterial strains has heightened the need for effective and affordable antibiotic therapy, making amoxicillin a preferred first-line treatment option[1][3][4].
  • Improving Healthcare Infrastructure and Access: Expanding healthcare infrastructure, improving access to healthcare services, and increasing healthcare expenditure in emerging economies are creating opportunities for market expansion and penetration of amoxicillin[1][3][4].

Market Segmentation

By Infection Type

The amoxicillin market is segmented by various infection types, including skin infections, ear, nose, and throat (ENT) infections, stomach infections, lung infections, urinary tract infections (UTI), pneumonia, bronchitis, and gonorrhea. Each segment contributes significantly to the overall market growth due to the broad therapeutic utility of amoxicillin[1][3][4].

By Route of Administration

Amoxicillin is administered through various routes, including oral and intravenous. The oral route is the most common due to its ease of administration and patient compliance[1][3].

By Form

The market is segmented by form, including tablets, capsules, suspensions, syrups, and powders. Oral formulations, particularly tablets and suspensions, dominate the market due to their convenience and efficacy[1][3][4].

By Distribution Channels

The distribution channels include hospitals, retail pharmacies, online pharmacies, and others. Hospitals and retail pharmacies are the primary distribution channels, ensuring widespread availability of amoxicillin[1][3].

Regional Analysis

  • North America: This region is expected to dominate the amoxicillin market due to the high incidence of bacterial infections, well-established healthcare infrastructure, and widespread availability of antibiotics. High investment in clinical trials and R&D spending further supports market growth[1][3][4].
  • Europe: Europe follows closely, driven by increasing healthcare expenditure and government initiatives to combat antibiotic resistance. The region's strong healthcare infrastructure and high demand from both domestic and international markets contribute to its significant market share[1][3][4].
  • Asia Pacific: This region is anticipated to witness rapid growth, fueled by a large population base, improving access to healthcare services, and rising awareness about infectious diseases. Countries like China, India, Japan, South Korea, and Australia are key markets in this region[1][3][4].
  • Latin America and Middle East & Africa: These regions are also expected to experience significant growth due to improving healthcare infrastructure, increasing investments in healthcare, and a rising burden of bacterial infections[1][3][4].

Price Trends and Projections

Current Price Trends

The price of amoxicillin has shown varying trends across different regions. In Asia, the price trend has been fluctuating due to factors such as supply chain disruptions, logistical challenges, and changes in demand from downstream industries[2]. In Europe, the price trend has been gradually increasing due to strong demand from domestic and international markets, coupled with logistical hurdles and higher shipping costs[2]. In North America, the price trend has been positive, driven by strong domestic demand from the healthcare sector and supply constraints[2].

Future Price Projections

Analysts predict that the price of amoxicillin will likely depict a mixed trend. While there are expectations of a declining trend due to rising inflation rates and slow demand from end-user industries, other factors such as positive demand projections and limited supply scenarios suggest potential price increases[2]. For the second half of 2024, the price trend is expected to remain stable in some regions but could face challenges from oscillations in crude oil prices and poor procurement from downstream industries[2].

Challenges and Opportunities

  • Antibiotic Stewardship Initiatives: These initiatives aim to promote the rational use of antibiotics, which can impact market growth. However, they also present opportunities for market players to innovate and differentiate their products[1][3][4].
  • Regulatory Requirements: Compliance with regulatory requirements can be a challenge, but it also ensures the quality and safety of amoxicillin, which is crucial for market credibility[1][3][4].
  • Competition from Alternative Therapies: The market faces competition from alternative antibiotic agents and therapeutic modalities. However, the broad therapeutic utility and clinical effectiveness of amoxicillin maintain its market position[1][3][4].

Key Players and Market Strategies

Several key players, including Novartis, Dr. Reddy Laboratories, JAMP Pharma Corporation, Northwind Pharmaceuticals, Profecient Ex LP, and Sun Pharmaceuticals, are active in the amoxicillin market. These companies are focusing on expanding their production volumes, innovating product forms, and collaborating with healthcare providers and policymakers to address antibiotic resistance and promote rational antibiotic use[1][3][4].

Macro Economic Scenario

  • Impact of High Inflation: High inflation rates can slow down market activities and affect the demand for amoxicillin. However, the essential nature of antibiotics in healthcare mitigates some of these effects[4].
  • Ukraine-Russia War Impact: Geopolitical tensions can affect shipping routes and supply chains, leading to price fluctuations and market instability[4].
  • COVID-19 Impact: The COVID-19 pandemic has highlighted the importance of robust healthcare infrastructure and the need for effective antibiotics, which has positively impacted the amoxicillin market[4].

Key Takeaways

  • The global amoxicillin market is expected to grow significantly due to increasing bacterial infections and the need for effective antibiotic therapy.
  • North America and Europe are the dominant regions, with the Asia Pacific region showing rapid growth.
  • Price trends are expected to be influenced by supply chain dynamics, demand from downstream industries, and geopolitical factors.
  • Key players are focusing on innovation, production expansion, and collaboration to address antibiotic resistance.

Frequently Asked Questions (FAQs)

1. What is the current market size of the global amoxicillin market? The global amoxicillin market was valued at approximately $4.9 billion in 2024[1].

2. What is the expected CAGR of the global amoxicillin market from 2024 to 2033? The market is expected to grow at a CAGR of approximately 2.5% from 2024 to 2033[1].

3. Which regions are expected to dominate the amoxicillin market? North America and Europe are expected to dominate the market, with the Asia Pacific region showing rapid growth[1][3][4].

4. What are the main factors driving the growth of the amoxicillin market? The main factors include the increasing prevalence of bacterial infections, antibiotic resistance, and improving healthcare infrastructure and access[1][3][4].

5. How are price trends expected to evolve for amoxicillin in the future? Price trends are expected to be mixed, with potential declines due to inflation and slow demand but also potential increases due to positive demand projections and limited supply scenarios[2].

Sources:

  1. Custom Market Insights: Global Amoxicillin Market Size, Trends, Share, Forecast 2033[1]
  2. Procurement Resource: Amoxicillin Price Trend and Forecast[2]
  3. Fact.MR: Amoxicillin Drugs Market Share and Statistics - 2034[3]
  4. The Business Research Company: Amoxicillin Market Report 2024: Comprehensive Market Growth and ...[4]

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.